Lidocaine Combined Dexmedetomidine for Obturator Nerve Block
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Dexmedetomidine as an adjuvant of lidocaine can decrease the median effective
concentration(EC50) of lidocaine for obturator nerve block during transurethral resection of
bladder tumor